WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009134380) SUPER FAST-ACTING INSULIN COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/134380    International Application No.:    PCT/US2009/002625
Publication Date: 05.11.2009 International Filing Date: 28.04.2009
Chapter 2 Demand Filed:    26.02.2010    
IPC:
A61K 38/28 (2006.01), A61K 38/47 (2006.01), A61P 5/50 (2006.01), A61P 3/10 (2006.01)
Applicants: HALOZYME, INC. [US/US]; 11388 Sorrento Valley Road San Diego, CA 92121 (US) (For All Designated States Except US).
FROST, Gregory, I. [US/US]; (US) (For US Only).
BILINSKY, Igor [US/US]; (US) (For US Only).
VAUGHN, Daniel [US/US]; (US) (For US Only).
SUGARMAN, Barry [US/US]; (US) (For US Only)
Inventors: FROST, Gregory, I.; (US).
BILINSKY, Igor; (US).
VAUGHN, Daniel; (US).
SUGARMAN, Barry; (US)
Agent: SEIDMAN, Stephanie, L.; K&L Gates LLP 3580 Carmel Mountain Road Suite 200 San Diego, CA 92130 (US).
BALDOCK, Sharon, Claire; Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT (GB)
Priority Data:
61/127,044 09.05.2008 US
61/125,835 28.04.2008 US
Title (EN) SUPER FAST-ACTING INSULIN COMPOSITIONS
(FR) COMPOSITIONS D'INSULINE À ACTION SUPER-RAPIDE
Abstract: front page image
(EN)Provided are combinations, compositions and kits containing an fast-acting insulin composition and a hyaluronan degrading enzyme composition formulated for parenteral administration. Such products can be used in methods of treating insulin- treatable diseases or conditions. Also provided are methods for administration of a fast-acting insulin and a hyaluronan degrading enzyme.
(FR)La présente invention concerne des combinaisons, compositions et nécessaires contenant une composition d'insuline à action rapide et une composition de hyaluronidase, qui sont formulées en vue d'une administration par voie parentérale. Lesdits produits peuvent être utilisés dans le cadre de procédés de traitement de maladies ou d'affections susceptibles d'être traitées par l'insuline. L'invention concerne également des procédés d'administration d'une insuline à action rapide et d'une hyaluronidase.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)